Hospira 3Q Revenues: $925.5 million (+10%) 3Q Earnings: $81.8 million (+38%) YTD Revenues: $2.7 billion (+9%) YTD Earnings: $216.3 million (earnings were $60.7 million YTD07) Comments: Revenue growth in the quarter was driven by strong sales in Specialty Injectable Pharmaceuticals as well as increased demand in Medication Management Systems product lines. Sales increased in all segments: the Americas (+10%); Europe (+10%), Middle East and Africa (EMEA) (+23%). YTD07 earnings refle...